Two novel sub-types of multiple sclerosis (MS) have been identified, a discovery potentially paving the way for new treatments.
Researchers employed artificial intelligence (AI) to assess brain scans and levels of serum neurofilament light chain (sNfL), a blood marker for nerve cell injury.